Hedwig E. Deubzer
Impact in
- Neurology top 2%
- Neuroblastoma Research and Treatments
- Molecular Biology top 2%
- Histone Deacetylase Inhibitors Research
- Protein Degradation and Inhibitors
- Epigenetics and DNA Methylation
- Ubiquitin and proteasome pathways
Papers in
- Neurology 37
- Neuroblastoma Research and Treatments 36
-
- Histone Deacetylase Inhibitors Research 20
- Protein Degradation and Inhibitors 17
- Cancer therapeutics and mechanisms 5
- Epigenetics and DNA Methylation 5
- Co-authors
- Olaf Witt (26 shared papers)Ina Oehme (17 shared papers)Till Milde (14 shared papers)Marco Lodrini (19 shared papers)Matthias Fischer (11 shared papers)Annette Kopp‐Schneider (6 shared papers)Andreas von Deimling (7 shared papers)Frank Westermann (6 shared papers)
- Journals
- Cancer Letters (4 papers)Oncotarget (4 papers)International Journal of Cancer (4 papers)Clinical Cancer Research (3 papers)Cell Death and Disease (3 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Hedwig E. Deubzer
60 papers receiving 3.7k citations
Hedwig E. Deubzer's Hit Papers
Peers
Comparison fields: 5 of 116
- Neurology 734
- Molecular Biology 2.9k
- Oncology 1.1k
- Cancer Research 545
- Genetics 313
Countries citing papers authored by Hedwig E. Deubzer
This map shows the geographic impact of Hedwig E. Deubzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hedwig E. Deubzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hedwig E. Deubzer more than expected).
Fields of papers citing papers by Hedwig E. Deubzer
This network shows the impact of papers produced by Hedwig E. Deubzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hedwig E. Deubzer. The network helps show where Hedwig E. Deubzer may publish in the future.
Co-authors
The 25 scholars most cited alongside Hedwig E. Deubzer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 64 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | HDAC family: What are the cancer relevant targets? Hit paper breakdown → | 2008 | 871 |
| 2 | 2008 | 320 | |
| 3 | 2013 | 223 | |
| 4 | 2013 | 165 | |
| 5 | 2013 | 159 | |
| 6 | 2010 | 158 | |
| 7 | 2015 | 142 | |
| 8 | 2009 | 95 | |
| 9 | 2012 | 90 | |
| 10 | 2012 | 84 | |
| 11 | 2010 | 81 | |
| 12 | 2013 | 75 | |
| 13 | 2017 | 66 | |
| 14 | 2017 | 65 | |
| 15 | 2009 | 65 | |
| 16 | 2011 | 64 | |
| 17 | 2011 | 58 | |
| 18 | 2015 | 57 | |
| 19 | 2009 | 53 | |
| 20 | 2017 | 50 |
About Hedwig E. Deubzer
Hedwig E. Deubzer is a scholar working on Neurology, Molecular Biology, Oncology, Cancer Research and Genetics, having authored 64 papers that have together received 3.7k indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (36 papers), Histone Deacetylase Inhibitors Research (20 papers), Protein Degradation and Inhibitors (17 papers), Cancer, Hypoxia, and Metabolism (13 papers), Glioma Diagnosis and Treatment (8 papers), Cancer therapeutics and mechanisms (5 papers), Epigenetics and DNA Methylation (5 papers) and CAR-T cell therapy research (5 papers). The work is most often cited by research in Neurology (734 citations), Molecular Biology (2.9k citations), Oncology (1.1k citations), Cancer Research (545 citations) and Genetics (313 citations). Hedwig E. Deubzer has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Olaf Witt, Ina Oehme, Till Milde, Marco Lodrini, Matthias Fischer, Annette Kopp‐Schneider, Andreas von Deimling, Frank Westermann, Johannes H. Schulte and Andreas E. Kulozik. Their work appears in journals such as Cancer Letters, Oncotarget, International Journal of Cancer, Clinical Cancer Research and Cell Death and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.